THANK YOU U.S. Senator Bill Cassidy, M.D. for championing this bill that will allow more bone marrow donors to say yes! 💙 Clark Alsfeld and I really appreciated the chance to thank your office in person and discuss funding for the NMDP national registry and #SaveMoreLives. NMDP Advocacy

What an impactful week! We met with more than 100 Congressional offices in just one day to encourage elected officials to support the national registry and the Life Saving Leave Act to #SaveMoreLives. Thank you to all our advocates who attended and made their voices heard!

I’m very proud of this joint effort by ASTCT NMDP CIBMTR ASH and others including Stephanie Farnia Jugna Shah to secure this win for patients with MDS! And thank you CMSGov for seeking thoughtful input and for this compassionate and wise decision.

Very exciting new treatment options for our patients with chronic GVHD! #bmtsm onclive.com/view/fda-appro…

Join us and ASTCT for our Physician Exchange at #SOHO2024! Hear from our panel of experts on the latest in #MDS research, clinical trials and transplant insights—plus earn 1.0 CME credit! 📅 Sept. 4 | 11:46 a.m. 📍 GRB Convention Center | Room 350F 🔗 bit.ly/4dFAtp6

Thank you #SOHO2024 for reuniting us Mahmoud Gaballa Clark Alsfeld it’s been 3 years since we were all sitting in the SCTCT fellows room MD Anderson Cancer Center debating and learning together. We’re missing our 4th co-fellow Aimaz Afrough

Thank you NMDP for giving us the opportunity to discuss important issues in transplant for #MDS with Warren Fingrut Onyee Chan Taha A, MD hosted by Dr. Minoo Battiwalla at #SOHO2024 #bmtsm

ASTCT Government Affairs Committee and leadership members are preparing to discuss key initiatives and issues with congressional staff members at tomorrow's #ASTCTHillDay

Hill Day 2024 with ASTCT NMDP Advocacy advocating for Accelerating Kid's Access to Care Act, Alleviating Barriers for Caregivers Act, and NIH funding with Asmita Mishra, TL, and so many others! #ASTCTHillDay #bmtsm

The U.S. House of Representatives unanimously passed the Accelerating Kids' Access to Care Act! The act still needs to pass in the Senate and we need your help. If you haven't yet, message your U.S. Senators urging them to vote yes. ow.ly/h10s50TqtKF

Immensely grateful to have received this award from NMDP Advocacy NMDP, but even more honored to share it with Hillary Husband Nancy O Karen Kramer who are inspiring so many and increasing access to life-saving transplants #bmtsm #donorleaveact

Dive into our on-demand CME roundtable for insights on allogeneic HCT for high-risk patients with MDS. Hear from top hematology/oncology experts on best practices, current research and specific clinical scenarios. Access it now 👉 go.nmdp.org/4fAIUTF

Our new BMT CTN 1703 analysis busts a few myths: - QOL improved with ptCY - 🩸Cystitis not worse - 2yr GRFS superior 42% vs 29%, p=0.001 - ptCY relapse NOT higher Shernan Holtan MD Javier Bolaños Meade, MD TY to Mike Martens for elegant analysis #GvHD #alloHCT #BMT ascopubs.org/doi/10.1200/JC…

This year I am participating in the Leukemia Lymphoma Society Visionary of the Year campaign. Please consider supporting in any way! pages.lls.org/voy/msla/nola2…

Always great having you take a trip down the road to visit! Ochsner Cancer Institute MD Anderson Cancer Center

We're proud to support Clark Alsfeld for LLS Visionary of the Year! ❤️ A true advocate for the cancer community, Clark is making a difference—and there’s still time to support his campaign before June 14! Donate here: tinyurl.com/calsfeld #CancerAdvocacy #VisionaryOfTheYear

Out now! 🎉 In this opening segment from an expert panel discussion, Drs. Saeed Sadeghi (UCLA Health), Clark Alsfeld (Ochsner Health), Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (Duke Health), and Raji Shameem (Orlando Health) discuss first-line management for low-risk #MDS. ➡️ buff.ly/41JBrfS

In the next #MDS roundtable episode, Drs. Saeed Sadeghi (UCLA Health), Clark Alsfeld (Ochsner Health), Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO (Duke Health), and Raji Shameem (Orlando Health) discuss the COMMANDS trial of luspatercept versus epoetin alfa. ➡️ buff.ly/V0VkH5Z